TipRanks
Axon Enterprise (MX:AXON)
:AXON
Mexico Market
EarningsQ2 2026 Earnings Report

Axon Enterprise (AXON) Q2 2026 Earnings Report

7 Followers

MX:AXON Q2 2026 EPS Results

Actual EPS$34.17
Consensus EPS$33.52
Beat/MissBeat by +$0.65
One Year Ago EPS$38.54

MX:AXON Q2 2026 Revenue Results

Actual Revenue$16.44B
Expected Revenue$15.93B
Beat/MissBeat by +$508.43M
YoY Revenue Growth+35.28%

Earnings Announcement Details

QuarterQ2 2026
Date08/05/2026
TimeAfter Close
Conference CallWednesday, August 5, 2026
MX:AXON Upcoming Earnings
Axon Enterprise's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MX:AXON Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong, broad-based growth across revenue, software, devices, bookings and international/enterprise markets, with notable product momentum (Dedrone > $100M, TASER 10, Axon Body deployments) and improved profitability metrics. Management raised revenue guidance and highlighted durable metrics (ARR +39%, NRR 126%). Headwinds are present—inventory-driven near-term free cash flow pressure, rising memory/component costs, tariff variability, product-mix impacts, and privacy/governance risks—that could compress margins in Q3 before normalization in Q4. Overall the positives —scale, accelerating software adoption (including AI), bookings momentum and raised guidance—significantly outweigh the transitory operational and mix challenges.
Company Guidance
Axon raised full-year revenue guidance to 32%–34% (up 200 bps from 30%–32%) while reiterating full‑year adjusted EBITDA margin of ~25.5% and a prior free cash flow target of $450M; management expects Q3 adjusted EBITDA to be pressured by higher memory costs with no tariff‑refund benefit, then margins scaling back in Q4 (seasonality similar to last year, with Q4 the strongest quarter). Supporting the outlook, Q2 results and bookings showed strong momentum — revenue $904M (+35% YoY), software & services $398M (+36%), connected devices $507M (+35%), platform solutions $150M (+123%), ARR +39% to $1.6B, NRR 126%, adjusted gross margin 62.9% (+130 bps sequential), adjusted EBITDA $242M (26.8% margin), operating cash flow $20M (vs -$92M prior year), free cash flow outflow $1M, Q2 gross bookings +20% YoY (five‑year normalized bookings +30%+ YoY with line of sight to finish the year in the ~30% range), and future contracted bookings >40% YoY to $15.1B; management also expects body‑camera shipments to rise ~20%–30% sequentially in Q3 (15%–20% q/q) and highlighted Dedrone surpassing $100M in quarterly revenue.
Record Quarterly Revenue and Strong Top-Line Growth
Revenue of $904 million, up 35% year-over-year; marked the 10th consecutive quarter of growth above 30% and management called it a record quarter.
Software & Services Expansion
Software and services revenue grew 36% YoY to $398 million; more than one-third of software revenue now comes from offerings beyond core Evidence and that segment grew ~70% YoY; AI Era Plan grew almost 700%.
Recurring Revenue and Retention Strength
Annual recurring revenue (ARR) increased 39% to $1.6 billion and net revenue retention (NRR) reached 126%, indicating strong expansion within the installed base.
Devices and Platform Momentum
Connected devices revenue grew 35% to $507 million; Platform Solutions revenue grew 123% to $150 million, with Dedrone (counter‑drone) surpassing $100 million in quarterly revenue.
Bookings Growth & Five-Year Normalized Momentum
Q2 gross bookings up 20% YoY; five-year normalized bookings up over 30% YoY; management sees line-of-sight to finish the year in the ~30% range on normalized bookings.
International, Enterprise, and Federal Traction
International bookings were ~3x prior year in Q2; enterprise bookings ~3x YoY; named a participant in the $1.5 billion DHS Counter‑UAS program and closed federal deployments including Axon Assistant.
Margins, Profitability and Cash Flow Improvement
Adjusted gross margin improved to 62.9% (up 130 basis points sequentially); adjusted EBITDA of $242 million (26.8% margin); operating cash flow improved to $20 million from an outflow of $92 million year-ago.
Raised Full-Year Revenue Guidance
Full-year revenue growth guidance raised to 32%-34% (200 basis points above prior 30%-32% range); reaffirmed full-year adjusted EBITDA margin target of ~25.5% and maintained free cash flow conversion objectives.
Large Strategic Wins & Product Adoption
Signed two nine-figure municipal deals (including largest-ever individual TASER order), two eight-figure state corrections deals, first full-scope Axon 911 customer, and reported strong early adoption for Axon Body Mini, Outpost/Lightpost and TASER 10 (booked more TASER 10 units than TASER 7 lifetime).

MX:AXON Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 10, 2026
2026 (Q3)
34.90 / -
21.268―
2026 (Q2)
33.52 / 34.17
38.538-11.32% (-4.36)
2026 (Q1)
29.03 / 29.27
25.63114.18% (+3.64)
2025 (Q4)
29.07 / 39.08
37.8113.37% (+1.27)
2025 (Q3)
27.65 / 21.27
26.358-19.31% (-5.09)
2025 (Q2)
26.45 / 38.54
21.81476.67% (+16.72)
2025 (Q1)
23.16 / 25.63
20.90522.61% (+4.73)
2024 (Q4)
25.52 / 37.81
20.3685.71% (+17.45)
2024 (Q3)
21.78 / 26.36
18.54242.16% (+7.82)
2024 (Q2)
18.60 / 21.81
20.1788.11% (+1.64)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed